Comparison of glimepiride and linagliptin in the treatment of non-alcoholic hepatic disease with type 2 diabetes mellitus

Comparison of glimepiride and linagliptin in the treatment of non-alcoholic hepatic disease with type 2 diabetes mellitus

Introduction Nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus (T2DM) is associated with severe clinical outcomes. MicroRNA (miR)-210 has been reported to be related to T2DM and lipid metabolism. This study aimed to determine whether miR-210 can predict the effects of glimepirid...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng Tian, Yali Guo, Liping Zhou, Qunying Yao, Xiaoyan Liang, Jiaxin Lu, Aiping He, Jie Shen
Format: Article
Language:English
Published: Termedia Publishing House 2023-02-01
Series:Archives of Medical Science
Subjects:
linagliptin
glimepiride
type 2 diabetes mellitus
non-alcoholic fatty hepatic disease
mirna-210
Online Access:https://www.archivesofmedicalscience.com/Comparison-of-glimepiride-and-linagliptin-in-the-treatment-of-non-alcoholic-hepatic,161228,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.archivesofmedicalscience.com/Comparison-of-glimepiride-and-linagliptin-in-the-treatment-of-non-alcoholic-hepatic,161228,0,2.html

Similar Items